Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Sponsor: EXACT Therapeutics AS
ClinicalTrials ID:NCT06850623
This study evaluates the efficacy and safety of Acoustic Cluster Therapy (ACT) combined with modified FOLFIRINOX chemotherapy in patients with inoperable or borderline resectable locally advanced pancreatic cancer. ACT involves PS101 and ultrasound, administered on Day 1 of each chemotherapy cycle. Eligibility requires suitability for mFOLFIRINOX and inoperable LAPC. Efficacy is assessed via CT scans every 8 weeks.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
Description
Patients with Locally Advanced Pancreatic Cancer who have not received prior treatment to their pancreatic cancer will receive ACT treatment (the drug PS101 and ultrasound application to the tumor) with up to eight 2-week cycles of modified FOLFIRINOX chemotherapy.
ACT treatment will be given on Day 1 of each cycle of chemotherapy. Patients' well-being and side effects will be assessed at the same visits. The objective efficacy of the treatment will be assessed by CT scans every 8 weeks.
Eligibility Criteria
Inclusion Criteria
- Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline resectable pancreatic cancer.
- Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.
Exclusion Criteria
• Any prior anti-cancer treatment for pancreatic cancer (e.g. chemotherapy, surgery, radiation). Palliative bypass procedure and bile duct stenting are allowed.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| HonorHealth Research Institute | 85258 | Scottsdale | Arizona |
| Henry Ford Centre | 48202 | Detroit | Michigan |
| Allegheny General Hospital | 15212 | Pittsburgh | Pennsylvania |
| Brown University Cancer Institute | 02906 | Providence | Rhode Island |
Get This Program In Your Inbox
You can sign up and apply your patients for this program.